Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas. - Wilky BA; Schwartz GK; Gordon MS; El-Khoueiry AB; Bullock AJ; Henick B; Agulnik M; Singh A; Mahadevan D; Stebbing J; Delepine C; Chand D; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025)